| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |